Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Indication for cardiac resynchronization therapy: Consensus 2005].

C W Israel1, C Butter

  • 1J.-W.-Goethe-Universitätsklinik, Medizinische Klinik III-Kardiologie, Theodor-Stern-Kai 7, 60590 Frankfurt. C.W.Israel@em.uni-frankfurt.de

Herzschrittmachertherapie & Elektrophysiologie
|April 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cardiac implantable electronic device-related surgery as a perfect example for interdisciplinary cooperation].

Herzschrittmachertherapie & Elektrophysiologie·2025
Same author

[You can only understand today if you know yesterday : The history of rhythmology in Germany].

Herzschrittmachertherapie & Elektrophysiologie·2024
Same author

[Electrophysiology goes imaging!]

Herzschrittmachertherapie & Elektrophysiologie·2022
Same author

[Surprising mechanism of highly symptomatic tachycardia in a young patient : Diagnosis and treatment].

Herzschrittmachertherapie & Elektrophysiologie·2021
Same author

[Echocardiographic assessment of myocardial function during His bundle and right ventricular pacing].

Herzschrittmachertherapie & Elektrophysiologie·2020
Same author

Impact of mapping points in high-density mapping of the left atrium.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2019
Same journal

[Extrasystoles in endurance athletes].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[AI-Assisted ECG diagnostics : Classical test statistics still apply].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Perioperative complications during transvenous pacemaker and defibrillator implantation].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Late complications after atrial fibrillation ablation : Diagnosis and management].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same journal

[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary].

Herzschrittmachertherapie & Elektrophysiologie·2026
See all related articles

Cardiac resynchronization therapy (CRT) offers significant benefits for heart failure patients with specific criteria, including NYHA class III/IV and QRS duration over 130 ms. Careful patient selection optimizes CRT outcomes and avoids invasive treatment in unlikely responders.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) aims to improve outcomes in heart failure patients.
  • Optimizing CRT patient selection is crucial to maximize symptomatic benefit and avoid invasive procedures in non-responders.

Framework:

  • Established 2005 consensus indicates CRT for NYHA class III/IV heart failure, LVEF ≤35%, QRS duration >130 ms (especially with LBBB), and sinus rhythm.
  • CRT may be indicated for atrial fibrillation patients meeting these criteria.
  • Uncertainty exists for CRT in other intraventricular conduction delays; LBBB with QRS 120-130 ms may benefit if echocardiography shows dyssynchrony.

Implementation:

  • Echocardiographic criteria for ventricular dyssynchrony alone are not established indications without QRS duration ≥120 ms.

Related Experiment Videos

  • Ongoing trials (RAFT, MADIT-CRT) investigate CRT for NYHA class II heart failure.

    • Implications:

    • Refined patient selection for CRT enhances therapeutic efficacy.
    • Further research is needed to clarify CRT indications in specific patient subgroups and with evolving diagnostic criteria.
    • Personalized medicine approaches in CRT are essential for improved patient management.